Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb 22;3(6):55-62.
doi: 10.1098/rsif.2005.0079.

Infectious disease control using contact tracing in random and scale-free networks

Affiliations

Infectious disease control using contact tracing in random and scale-free networks

Istvan Z Kiss et al. J R Soc Interface. .

Abstract

Contact tracing aims to identify and isolate individuals that have been in contact with infectious individuals. The efficacy of contact tracing and the hierarchy of traced nodes-nodes with higher degree traced first-is investigated and compared on random and scale-free (SF) networks with the same number of nodes N and average connection K. For values of the transmission rate larger than a threshold, the final epidemic size on SF networks is smaller than that on corresponding random networks. While in random networks new infectious and traced nodes from all classes have similar average degrees, in SF networks the average degree of nodes that are in more advanced stages of the disease is higher at any given time. On SF networks tracing removes possible sources of infection with high average degree. However a higher tracing effort is required to control the epidemic than on corresponding random networks due to the high initial velocity of spread towards the highly connected nodes. An increased latency period fails to significantly improve contact tracing efficacy. Contact tracing has a limited effect if the removal rate of susceptible nodes is relatively high, due to the fast local depletion of susceptible nodes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Possible transitions among the five different classes and the corresponding rates of transitions.
Figure 2
Figure 2
Time evolution of the proportion of infectious nodes for random (a) and scale-free (SF), (b) networks in the absence of tracing with rSE=0.015,0.0215,…,0.08 and Lat_P=3.5.
Figure 3
Figure 3
Final epidemic size representing the number of nodes that became infectious during the whole epidemic, plotted as a function of rSE in the absence of tracing. Continuous line corresponds to random networks and dashed line to SF networks. The latency period is Lat_P=3.5.
Figure 4
Figure 4
Proportion of infected nodes removed by tracing for random (a) and SF (b) networks for rSE=0.15 and Lat_P=3.5.
Figure 5
Figure 5
Proportion of infected nodes removed by tracing for random (a) and SF (b) networks for rSE=0.15 and Lat_P=10.0.
Figure 6
Figure 6
Average degree of new infectious nodes, and average degree of susceptible and infected nodes removed by tracing versus time for random (a) and SF (b) networks for rSE=0.15, Lat_P=10.0 and rSR=rER=rIR=0.5.
Figure 7
Figure 7
The daily average degree and number (inset) of new infectious nodes versus time for different levels of tracing (rER=rIR=0.5 and 1.6). Results obtained using SF networks for rSE=0.15, Lat_P=10.0 and rSR=0.5.

Similar articles

Cited by

References

    1. Albert R, Barabási A.L. Statistical mechanics of complex networks. Rev. Mod. Phys. 2002;74:47–97. doi:10.1103/RevModPhys.74.47 - DOI
    1. Albert R, Jeong H, Barabási A.L. Error and attack tolerance of complex networks. Nature. 2000;406:378–382. doi:10.1038/35019019 - DOI - PubMed
    1. Anderson R.M, May R.M. Oxford University Press; Oxford: 1991. Infectious diseases of humans: dynamics and control.
    1. Barthélemy M, Barrat A, Pastoras-Satorras R, Vespignani A. Velocity and hierarchical spread of epidemic outbreaks in scale-free networks. Phys. Rev. Lett. 2004;92:178701. doi:10.1103/PhysRevLett.92.178701 - DOI - PubMed
    1. Clarke J. Contact tracing for Chlamydia: data on effectiveness. Int. J. STD AIDS. 1998;9:187–191. doi:10.1258/0956462981921945 - DOI - PubMed

Publication types